{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-112896","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.669754+00:00","generated_at":"2026-05-30T07:34:04.208886+00:00","sec_items":["1.01","3.02","5.01","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aerovate to merge with Jade Biosciences; Jade holders to own 98.4%","bullets":["Aerovate (AVTE) reverse-merges with Jade; pre-merger Jade stockholders receive 98.4% of combined firm; Aerovate holders receive 1.6%.","Concurrent ~$300M PIPE led by existing Jade investors, including conversion of $95M convertible notes.","Aerovate to pay ~$65M cash dividend to its pre-merger stockholders; combined company renamed Jade Biosciences, expects ticker 'JBIO'.","Post-closing board will be six members, all designated by Jade; closing requires stockholder and regulatory approvals."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-112896","json":"https://secwatch.observer/filing/0001104659-24-112896.json","markdown":"https://secwatch.observer/filing/0001104659-24-112896.md","text":"https://secwatch.observer/filing/0001104659-24-112896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000110465924112896/0001104659-24-112896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000110465924112896/tm2427147d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:34:04.208886+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}